Y. Yen, S. So, M. Rose, M. W. Saif, E. Chu, S. H. Liu, et al., “Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma,” Anticancer Research, Vol. 29, No. 10, 2009, pp. 4083-4092.

has been cited by the following article:

• TITLE: Translational Chinese Medicine: A Way for Development of Traditional Chinese Medicine

  AUTHORS: Xuegang Sun, Donglan Lin, Weikang Wu, Zhiping Lv

  KEYWORDS: Translational Medicine, Traditional Chinese Medicine, Quality Control, Efficacy, Safety

  JOURNAL NAME: Chinese Medicine, Vol.2 No.4, December 9, 2011

  ABSTRACT: Translational Chinese medicine is one of the latest developing fields in traditional Chinese medicine. In this paper, we discuss the “3 w” namely, “what is”, “why to advance”, “how to carry out” and the significance of translational Chinese medicine. To overcome the innate drawbacks of traditional Chinese medicine (TCM), the basic theory of TCM had better be refreshed. The safety and efficacy of classic formulae and therapy experience of TCM should be evaluated based on strict quality control and reaffirmed with evidence based medicine. The significance of translational Chinese medicine is to transform Chinese medicine into a balanced, personalized medicine with sound safety, good efficacy and strict quality control.